Clinical Trials
2 trialsNCT05741164 2026-06-04
Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer
Emory University
Phase 2 Recruiting
NCT07583134 2026-05-15
B-BIT
Seoul St. Mary's Hospital
Phase 4 Not yet recruiting